Uncategorised - European Medical Journal

DMT Rapidly Reduces Major Depression Symptoms

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting psychedelic approach.

Bimekizumab Sustains 3-Year Benefits in Psoriasis

Three-year BE RADIANT results highlight durable bimekizumab benefits in plaque psoriasis, improving PROs and QoL. Read more.

Cannabis Use Associated with Worse Working Memory

Heavy cannabis use linked to reduced brain activation during memory tasks, raising concerns about lasting cognitive health effects.

Childhood Interstitial Lung Disease and Quality of Life

A European study finds hospitalisations and insufficient growth reduce health-related quality of life in childhood interstitial lung disease.

Metastatic Breast Cancer Shows Biomarker Differences

Metastatic ILC shows significant biomarker heterogeneity, limiting single biopsy reliability and highlighting challenges in detection and monitoring.

Multicomponent Vaccine Shows Promise Against Flu and COVID-19

A single-dose multicomponent mRNA vaccine elicits durable immune responses against influenza and COVID-19 in a Phase 1/2 trial.

Clinician reviewing eye imaging and notes, representing large language models in glaucoma clinical decision support

Large Language Models in Glaucoma Need Guardrails

Large language models in glaucoma show promise for education and decision support, yet performance varies widely.

Doctor points to a hip X ray while explaining hip involvement in axial spondyloarthritis to a patient, holding a pelvis and femur anatomy model.

Hip Involvement Signals Severe Axial Spondyloarthritis

In outpatient axial spondyloarthritis care, radiographic hip involvement affected 13.90% and aligned with greater severity overall.

The Fertility Fix: Regenerating Testicular Function

In this new series, host Catherine Glass speaks with Peter N. Schlegel about the future of male infertility treatment. From decoding…

Type 2 Diabetes Treatment Overhaul Set to Save 17,000 Lives

Prescribing patients with type 2 diabetes SGLT-2 inhibitors much earlier in the treatment process could prevent around 17,000 deaths in the UK, new NICE guidance suggests.